ClinConnect ClinConnect Logo
Search / Trial NCT04682340

Analysis of BPA Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid Disease

Launched by JAGIELLONIAN UNIVERSITY · Dec 18, 2020

Trial Information

Current as of May 08, 2025

Completed

Keywords

Bisphenol A Bpa Hashimoto's Disease Graves' Disease

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Graves' disease or Hashimoto's disease (positive thyroid autoantibody)
  • Control group: thyroid autoantibody negative, normal thyroid function
  • Women aged 18 to 45 in both the control group and experimental group
  • Exclusion Criteria:
  • Pregnancy and lactating women
  • Previous or planned treatment with 131I or thyroidectomy
  • The use of drugs affecting the thyroid function (lithium, amiodarone, interferon a, sodium nitroprusside, sunitinib, sorafenib, iodine contrast, antibiotics / antifungals / antivirals (for at least 4 weeks prior to recruitment to the study), which do not result from the treatment of thyroid disease (levothyroxine, thyreostatic drugs, glucocorticoids)
  • Active malignancy
  • Other autoimmune diseases
  • Other endocrine diseases
  • Patients with severe liver, kidney or heart failure

About Jagiellonian University

Jagiellonian University, one of the oldest and most prestigious institutions of higher education in Poland, is a leading sponsor of clinical trials dedicated to advancing medical research and healthcare innovation. With a strong commitment to scientific excellence, the university leverages its extensive resources, multidisciplinary expertise, and collaborative network to conduct rigorous clinical studies that contribute to the development of new therapies and treatment strategies. Jagiellonian University emphasizes ethical research practices and strives to enhance patient outcomes through evidence-based findings, making significant contributions to the global medical community.

Locations

Kraków, Malopolska, Poland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials